COVID-19 Seroprevalence Survey among Cancer Patients and Caregivers in Cancer Center

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20201214005

Enrollment

400

Registered

2020-12-14

Start date

2020-12-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID&#45

Interventions

Cancer patients who was diagnosed and treated at Chulabhorn Hospital,Caregiver who spend their time within 1 month with cancer patient before enrolment

Screening,Screening

Cancer patients,Cancer caregiver

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Cancer patients who received treatment at Chulabhorn Hospital 2. Cancer caregiver matched with cancer patients

Exclusion criteria

Exclusion criteria: Previous COVID-19 infection

Design outcomes

Primary

Measure	Time frame
Seroprevalence of COVID-19 among cancer patient and cancer caregiver At the beginning of the study Immunoassay	—

Secondary

Measure	Time frame
Correlation between seroprevalance of cancer patient and care giver At the beginning of the study Immunoassay	—

Countries

Thailand

Contacts

Public ContactTeerapat Ungtrakul

Faculty of Medicine and Public Health, Chulabhorn Royal Academy

teerapat.ung@pccms.ac.th025766600

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026